avelumab,domvanalimab,zimberelimab,sacituzumab govitecan,pembrolizumab,sacituzumab govitecan
merck,otsuka,gilead sciences,pfizer,gilead,arcus biosciences
['muc ,(-much)', 'sacituzumab', 'urothelial', ' sg ', 'tropics-04', 'trophy,u-01', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
#gu23 presents cohort 2 of trophy-u-01 (phase-2) study evakuating sacituzumab govetin in platinum ineligible pts with metastatic #urothelialcancer (after pod on io) - in pt-ineligible orr: 32% - in chemo/ev naive: orr: 53.8%
- phase-iii tropics-04 going on 
GU Oncologist/Clinical Trials/ Experimental Therapeutics @UCD_Cancer @UCDavisHealth via @uofcincy @GoBEARCATS. Tweets= My opinions #RCC #ASCO #immunotherapy